The cardiovascular implants market size has grown strongly in recent years. It will grow from $28.68 billion in 2025 to $30.52 billion in 2026 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to increasing prevalence of cardiovascular diseases, rising interventional cardiology procedures, expansion of hospital cardiac care units, growing adoption of implantable pacemakers, availability of advanced biomaterials.
The cardiovascular implants market size is expected to see strong growth in the next few years. It will grow to $39.09 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing aging population, rising demand for minimally invasive cardiac treatments, expansion of structural heart disease therapies, growing focus on personalized cardiovascular care, increasing innovation in implant materials and designs. Major trends in the forecast period include increasing adoption of minimally invasive cardiovascular implants, rising use of drug-eluting and bioabsorbable stents, growing preference for transcatheter heart valve procedures, expansion of advanced cardiac rhythm management devices, enhanced focus on long-term implant durability.
The increasing prevalence of heart disorders is anticipated to drive the growth of the cardiovascular implants market in the coming years. Heart disorders encompass a range of medical conditions impacting the heart and blood vessels, such as coronary artery disease, heart failure, arrhythmias, and valve disorders. The demand for cardiovascular implants, including stents and pacemakers, is fueled by the rise in heart diseases like coronary artery disease and heart failure, as these implants help support heart function and circulation in heart failure patients, regulate heart rhythm, and monitor heart activity. For example, in September 2024, the British Heart Foundation (BHF), a UK-based charity focused on funding research and raising awareness about heart and circulatory diseases, reported that approximately 7.6 million individuals in the UK suffer from heart and circulatory diseases. By 2030, this number could increase by 1 million, and by 2040, it may grow by an additional 2 million. Therefore, the growing prevalence of heart disorders is boosting the cardiovascular implants market.
Leading companies in the cardiovascular implants market are intensifying their focus on incorporating advanced technology, including artificial intelligence (AI), to optimize market profits and enhance precision in patient care and treatment. Advancements in cardiac monitoring technology involve continuous tracking and recording of a patient's heart activity for the diagnosis and management of heart conditions. In June 2023, BIOTRONIK SE & Co. KG launched the BIOMONITOR IV implantable cardiac monitor (ICM), the first globally, combining SmartECG technology with artificial intelligence. This innovation reduces false-positive detections by 86% while retaining 98% accuracy in detecting real episodes. BIOMONITOR IV offers additional benefits, including extended battery life and wireless connectivity for smooth data transmission and remote monitoring, reducing the need for frequent in-person clinic visits.
In April 2023, Abbott Laboratories acquired Cardiovascular Systems Inc. for $890 million, aiming to enhance its solutions for treating vascular disease. This strategic acquisition makes Cardiovascular Systems Inc. a wholly owned subsidiary of Abbott and strengthens Abbott's position in providing innovative solutions for peripheral and coronary vascular disease.
Major companies operating in the cardiovascular implants market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Cook Medical Incorporated, Kyoto Medical Planning Co. Ltd., Abiomed Inc., Livanova PLC, BIOTRONIK SE & Co. KG, CryoLife Inc., Endologix Inc., Sorin Group, Berlin Heart GmbH, REVA Medical LLC., Syncardia Systems LLC, Elixir Medical Corporation, Proxy Biomedical Ltd., Calon Cardio-Technology Ltd., InspireMD Inc., Neovasc Inc., Shree Pacetronix Ltd., Vascutek Ltd.
North America was the largest region in the cardiovascular implants market in 2025. The regions covered in the cardiovascular implants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cardiovascular implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the cardiovascular implants market by increasing costs of imported metals, polymers, electronic components, and precision manufacturing equipment used in stents, pacemakers, valves, and defibrillators. Hospitals and cardiac centers in North America and Europe are most affected due to dependence on imported implant components, while Asia-Pacific faces cost pressure on export manufacturing. These tariffs are elevating device prices and affecting procurement budgets. At the same time, they are supporting localized manufacturing, regional supply chain development, and innovation in cost-optimized cardiovascular implant technologies.
The cardiovascular implants market research report is one of a series of new reports that provides cardiovascular implants market statistics, including cardiovascular implants industry global market size, regional shares, competitors with a cardiovascular implants market share, detailed cardiovascular implants market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular implants industry. This cardiovascular implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Cardiovascular implants are medical devices surgically placed within the cardiovascular system to manage heart and vascular conditions. These devices are strategically inserted into the cardiovascular system to address conditions such as blocked arteries, irregular heart rhythms, or valve defects. The primary goal is to restore normal heart function and improve blood circulation.
The main types of products categorized under cardiovascular implants include coronary stents, implantable cardioverter defibrillators (ICD), heart valves, implanted cardiac pacemakers, cardiac resynchronization therapy (CRT) devices, and peripheral stents. A coronary stent is a small mesh tube inserted into a narrowed or blocked coronary artery to maintain its openness. Various materials, including metals and alloys, polymers, and biological materials, are used in the manufacturing of these implants. They find applications in treating conditions such as arrhythmias, acute myocardial infarction, myocardial ischemia, and others. These cardiovascular implants are utilized by various end-users, including hospitals, ambulatory surgical centers, and cardiac centers.
The cardiovascular implants market consists of sales of aneurysm stent-grafts, cardiac resynchronization therapy (CRT) devices, ventricular assist devices, and peripheral vascular stents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The cardiovascular implants market size is expected to see strong growth in the next few years. It will grow to $39.09 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing aging population, rising demand for minimally invasive cardiac treatments, expansion of structural heart disease therapies, growing focus on personalized cardiovascular care, increasing innovation in implant materials and designs. Major trends in the forecast period include increasing adoption of minimally invasive cardiovascular implants, rising use of drug-eluting and bioabsorbable stents, growing preference for transcatheter heart valve procedures, expansion of advanced cardiac rhythm management devices, enhanced focus on long-term implant durability.
The increasing prevalence of heart disorders is anticipated to drive the growth of the cardiovascular implants market in the coming years. Heart disorders encompass a range of medical conditions impacting the heart and blood vessels, such as coronary artery disease, heart failure, arrhythmias, and valve disorders. The demand for cardiovascular implants, including stents and pacemakers, is fueled by the rise in heart diseases like coronary artery disease and heart failure, as these implants help support heart function and circulation in heart failure patients, regulate heart rhythm, and monitor heart activity. For example, in September 2024, the British Heart Foundation (BHF), a UK-based charity focused on funding research and raising awareness about heart and circulatory diseases, reported that approximately 7.6 million individuals in the UK suffer from heart and circulatory diseases. By 2030, this number could increase by 1 million, and by 2040, it may grow by an additional 2 million. Therefore, the growing prevalence of heart disorders is boosting the cardiovascular implants market.
Leading companies in the cardiovascular implants market are intensifying their focus on incorporating advanced technology, including artificial intelligence (AI), to optimize market profits and enhance precision in patient care and treatment. Advancements in cardiac monitoring technology involve continuous tracking and recording of a patient's heart activity for the diagnosis and management of heart conditions. In June 2023, BIOTRONIK SE & Co. KG launched the BIOMONITOR IV implantable cardiac monitor (ICM), the first globally, combining SmartECG technology with artificial intelligence. This innovation reduces false-positive detections by 86% while retaining 98% accuracy in detecting real episodes. BIOMONITOR IV offers additional benefits, including extended battery life and wireless connectivity for smooth data transmission and remote monitoring, reducing the need for frequent in-person clinic visits.
In April 2023, Abbott Laboratories acquired Cardiovascular Systems Inc. for $890 million, aiming to enhance its solutions for treating vascular disease. This strategic acquisition makes Cardiovascular Systems Inc. a wholly owned subsidiary of Abbott and strengthens Abbott's position in providing innovative solutions for peripheral and coronary vascular disease.
Major companies operating in the cardiovascular implants market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Cook Medical Incorporated, Kyoto Medical Planning Co. Ltd., Abiomed Inc., Livanova PLC, BIOTRONIK SE & Co. KG, CryoLife Inc., Endologix Inc., Sorin Group, Berlin Heart GmbH, REVA Medical LLC., Syncardia Systems LLC, Elixir Medical Corporation, Proxy Biomedical Ltd., Calon Cardio-Technology Ltd., InspireMD Inc., Neovasc Inc., Shree Pacetronix Ltd., Vascutek Ltd.
North America was the largest region in the cardiovascular implants market in 2025. The regions covered in the cardiovascular implants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cardiovascular implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the cardiovascular implants market by increasing costs of imported metals, polymers, electronic components, and precision manufacturing equipment used in stents, pacemakers, valves, and defibrillators. Hospitals and cardiac centers in North America and Europe are most affected due to dependence on imported implant components, while Asia-Pacific faces cost pressure on export manufacturing. These tariffs are elevating device prices and affecting procurement budgets. At the same time, they are supporting localized manufacturing, regional supply chain development, and innovation in cost-optimized cardiovascular implant technologies.
The cardiovascular implants market research report is one of a series of new reports that provides cardiovascular implants market statistics, including cardiovascular implants industry global market size, regional shares, competitors with a cardiovascular implants market share, detailed cardiovascular implants market segments, market trends and opportunities, and any further data you may need to thrive in the cardiovascular implants industry. This cardiovascular implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Cardiovascular implants are medical devices surgically placed within the cardiovascular system to manage heart and vascular conditions. These devices are strategically inserted into the cardiovascular system to address conditions such as blocked arteries, irregular heart rhythms, or valve defects. The primary goal is to restore normal heart function and improve blood circulation.
The main types of products categorized under cardiovascular implants include coronary stents, implantable cardioverter defibrillators (ICD), heart valves, implanted cardiac pacemakers, cardiac resynchronization therapy (CRT) devices, and peripheral stents. A coronary stent is a small mesh tube inserted into a narrowed or blocked coronary artery to maintain its openness. Various materials, including metals and alloys, polymers, and biological materials, are used in the manufacturing of these implants. They find applications in treating conditions such as arrhythmias, acute myocardial infarction, myocardial ischemia, and others. These cardiovascular implants are utilized by various end-users, including hospitals, ambulatory surgical centers, and cardiac centers.
The cardiovascular implants market consists of sales of aneurysm stent-grafts, cardiac resynchronization therapy (CRT) devices, ventricular assist devices, and peripheral vascular stents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Cardiovascular Implants Market Characteristics
3. Cardiovascular Implants Market Supply Chain Analysis
4. Global Cardiovascular Implants Market Trends and Strategies
5. Cardiovascular Implants Market Analysis of End Use Industries
7. Global Cardiovascular Implants Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Cardiovascular Implants Total Addressable Market (TAM) Analysis for the Market
9. Cardiovascular Implants Market Segmentation
10. Cardiovascular Implants Market Regional and Country Analysis
11. Asia-Pacific Cardiovascular Implants Market
12. China Cardiovascular Implants Market
13. India Cardiovascular Implants Market
14. Japan Cardiovascular Implants Market
15. Australia Cardiovascular Implants Market
16. Indonesia Cardiovascular Implants Market
17. South Korea Cardiovascular Implants Market
18. Taiwan Cardiovascular Implants Market
19. South East Asia Cardiovascular Implants Market
20. Western Europe Cardiovascular Implants Market
21. UK Cardiovascular Implants Market
22. Germany Cardiovascular Implants Market
23. France Cardiovascular Implants Market
24. Italy Cardiovascular Implants Market
25. Spain Cardiovascular Implants Market
26. Eastern Europe Cardiovascular Implants Market
27. Russia Cardiovascular Implants Market
28. North America Cardiovascular Implants Market
29. USA Cardiovascular Implants Market
30. Canada Cardiovascular Implants Market
31. South America Cardiovascular Implants Market
32. Brazil Cardiovascular Implants Market
33. Middle East Cardiovascular Implants Market
34. Africa Cardiovascular Implants Market
36. Cardiovascular Implants Market Competitive Landscape and Company Profiles
37. Cardiovascular Implants Market Other Major and Innovative Companies
40. Cardiovascular Implants Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Cardiovascular Implants Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses cardiovascular implants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for cardiovascular implants? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiovascular implants market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Coronary Stent; Implantable Cardioverter Defibrillator (ICD); Heart Valve; Implanted Cardiac Pacemaker; Cardiac Resynchronization Therapy (CRT) Devices; Peripheral Stent2) By Material: Metals and Alloys; Polymers; Biological Materials
3) By Application: Arrhythmias; Acute Myocardial Infarction; Myocardial Ischemia; Other Applications
4) By End-Users: Hospitals; Ambulatory Surgical Centers; Cardiac Centers
Subsegments:
1) By Coronary Stent: Drug-Eluting Stents; Bare-Metal Stents; Bioabsorbable Stents2) By Implantable Cardioverter Defibrillator (ICD): Single-Chamber ICD; Dual-Chamber ICD; Biventricular ICD
3) By Heart Valve: Mechanical Heart Valves; Biological Heart Valves; Transcatheter Heart Valves
4) By Implanted Cardiac Pacemaker: Single-Chamber Pacemaker; Dual-Chamber Pacemaker; Biventricular Pacemaker
5) By Cardiac Resynchronization Therapy (CRT) Devices: CRT-P Devices (Pacemakers); CRT-D Devices (Defibrillators)
6) By Peripheral Stent: Carotid Artery Stents; Renal Artery Stents; Femoral Artery Stents
Companies Mentioned: Abbott Laboratories; Medtronic PLC; Boston Scientific Corporation; B. Braun Melsungen AG; Edwards Lifesciences Corporation; W. L. Gore & Associates Inc.; Cook Medical Incorporated; Kyoto Medical Planning Co. Ltd.; Abiomed Inc.; Livanova PLC; BIOTRONIK SE & Co. KG; CryoLife Inc.; Endologix Inc.; Sorin Group; Berlin Heart GmbH; REVA Medical LLC.; Syncardia Systems LLC; Elixir Medical Corporation; Proxy Biomedical Ltd.; Calon Cardio-Technology Ltd.; InspireMD Inc.; Neovasc Inc.; Shree Pacetronix Ltd.; Vascutek Ltd
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Cardiovascular Implants market report include:- Abbott Laboratories
- Medtronic PLC
- Boston Scientific Corporation
- B. Braun Melsungen AG
- Edwards Lifesciences Corporation
- W. L. Gore & Associates Inc.
- Cook Medical Incorporated
- Kyoto Medical Planning Co. Ltd.
- Abiomed Inc.
- Livanova PLC
- BIOTRONIK SE & Co. KG
- CryoLife Inc.
- Endologix Inc.
- Sorin Group
- Berlin Heart GmbH
- REVA Medical LLC.
- Syncardia Systems LLC
- Elixir Medical Corporation
- Proxy Biomedical Ltd.
- Calon Cardio-Technology Ltd.
- InspireMD Inc.
- Neovasc Inc.
- Shree Pacetronix Ltd.
- Vascutek Ltd
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 30.52 Billion |
| Forecasted Market Value ( USD | $ 39.09 Billion |
| Compound Annual Growth Rate | 6.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
